Calian Group - CEO, Kevin Ford
CEO, Kevin Ford
Source: Ottawa Business Journal
Market Herald logo


Be the first with the news that moves the market
  • Calian Group (TSX:CGY) has won a contract to support the delivery of Mobile Respiratory Care Units for COVID-19 patients
  • The company was chosen by the joint venture between SNC-Lavalin and PAE, which is deploying care units across Canada
  • During Calian’s third and fourth quarters, its Health team will procure and deliver material, supplies, and expertise for the care units
  • The first project phase of the contract is valued at approximately C$24 million
  • Calian Group (CGY) is down 2.19 per cent and is currently trading at $50.00 per share

Calian Group (TSX:CGY) has won a contract to support the delivery of Mobile Respiratory Care Units for COVID-19 patients.

Mobile Respiratory Care Units are accessible, transportable, and easily storable units, containing 100 beds each. 

The care units also have triage areas, evaluation areas, resuscitation bays, inpatient wards, intensive care units, diagnostic imaging, and laboratory material.

The units are self-sufficient, ready-to-use, and will provide targeted care for people with acute respiratory distress and disease. Acute respiratory problems have been some of the defining characteristics of the ongoing COVID-19 pandemic.

Calian Group was chosen to assist in deploying the units, by a joint venture between SNC-Lavalin and PAE. The partnership is currently implementing care units in various locations across Canada, as part of the Government’s response to the pandemic.

Calian Group’s CEO, Kevin Ford, said that collaboration, flexibility, and innovation are key in the global response to COVID-19.

“At Calian, we have a solid track record with government and the private sector of providing innovative solutions for high-expectation industries.

“I am honoured that Calian’s exceptional team is a partner in this critical project to support readiness and help protect Canadians against this global health threat,” he said.

In the first project phase, Calian’s Health team will focus on coordinating, procuring, and delivering materials, supplies, and expertise. These efforts will support the delivery of up to ten care units.

The contract’s first project phase alone will be worth somewhere between C$22 million and $26 million, depending on demand. Calian Group expects to deliver the first phase of the project during its third and fourth quarters.

Calian’s Vice President of Health, Gordon McDonald, commented on the necessity of the project.

“This important project provides the Government of Canada with additional medical flexibility to help protect Canadians and provide additional surge capacity when and where needed. 

“The Calian Health team is privileged to contribute to the response efforts and ultimately help increase Canada’s response capabilities during this devastating pandemic,” he said.

Calian Group (CGY) is down 2.19 per cent and trading at $50.00 per share at 10:22am EDT.

More From The Market Herald

Optimi Health completes psilocybin extract validation

Optimi Health (CSE:OPTI) has reached a significant milestone, the successful harvest of eight new natural psilocybin genetics.

This stock is ready to capture the lead in the diabetes market

Diabetes specialist Glucotrack (NASDAQ:GCTK) has changed its business strategy to transition to continuous glucose monitoring.

Ceapro starts studies of flagship product for inflammation

Ceapro (TSXV:CZO) has launched a Phase 1 study evaluating its flagship product avenanthramides in managing inflammation-related conditions.